Mood after stroke: A case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Chatterjee, Kausik ^a   Fall, Susan ^b   Barer, David ^b  

^a Countess of Chester Hospital ^*  (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGED; ARTICLE; BASAL GANGLION; BIOCHEMISTRY; BLOOD PRESSURE MONITORING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; HYPERTENSION; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; SMOKING; SOCIOECONOMICS; STROKE; STRUCTURED INTERVIEW; SURVIVOR; WHITE MATTER; INTERVIEW; NONPARAMETRIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RADIOGRAPHY; RISK;

CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; HUMANS; HYPERTENSION; INTERVIEWS AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; RISK; SMOKING; STATISTICS, NONPARAMETRIC; STROKE;

EID: 78650602153     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-125     Document Type: Article

References (37)

1. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993, 24:976-982.
2. Davidson K, Jonas BS, Dixon KE, Markovitz JH. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary artery risk development in young adults. Arch Intern Med 2000, 160:1495-1500. 10.1001/archinte.160.10.1495, 10826464.
3. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001, 24:1069-1078. 10.2337/diacare.24.6.1069, 11375373.
4. Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000, 160:1354-1360. 10.1001/archinte.160.9.1354, 10809041.
5. Baldwin RC, Tomenson B. Depression in later life. A comparison of symptoms and risk factors in early and late onset cases. Br J Psychiatry 1995, 167:649-652. 10.1192/bjp.167.5.649, 8564322.
6. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M. Depression after stroke and lesion location: A systematic review. Lancet 2000, 356:122-126. 10.1016/S0140-6736(00)02448-X, 10963248.
7. Goldberg DWP. A user's guide to the General Health Questionnaire 1992, Windsor, NFER-Nelson.
8. Wade DT, Collin C. The Barthel ADL Index: A standard measure of physical disability?. Int Disabil Stud 1988, 10:64-67.
9. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, Washington, D.C.: American Psychiatric Association, 4, American Psychiatric Association.
10. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389. 10.1192/bjp.134.4.382, 444788.
11. Nelson E, Wasson J, Kirk J, Keller A, Clark D, Dietrich A, Stewart A, Zubkoff M. Assessment of function in routine clinical practice: Description of the coop chart method and preliminary findings. J Chronic Dis 1987, 40(Suppl 1):55S-69S. 10.1016/S0021-9681(87)80033-4, 3597698.
12. Lachs MS, Feinstein AR, Cooney LM, Drickamer MA, Marottoli RA, Pannill FC, Tinetti ME. A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med 1990, 112:699-706.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
14. Mittmann N, Herrmann N, Shulman KI, Silver IL, Busto UE, Borden EK, Naranjo CA, Shear NH. The effectiveness of antidepressants in elderly depressed outpatients: A prospective case series study. J Clin Psychiatry 1999, 60:690-697. 10.4088/JCP.v60n1008, 10549686.
15. Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing 1983, 12:166-170. 10.1093/ageing/12.2.166, 6869117.
16. Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989, 20:828.
17. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322.
18. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526. 10.1016/0140-6736(91)93206-O, 1675378.
19. Mulder RT, Joyce PR, Frampton C. Relationships among measures of treatment outcome in depressed patients. J Affect Disord 2003, 76:127-135. 10.1016/S0165-0327(02)00080-0, 12943942.
20. Schulz KF, Grimes DA. Case-control studies: Research in reverse. Lancet 2002, 359:431-434. 10.1016/S0140-6736(02)07605-5, 11844534.
21. Hackett ML, Anderson CS. Predictors of depression after stroke: A systematic review of observational studies. Stroke 2005, 36:2296-2301. 10.1161/01.STR.0000183622.75135.a4, 16179565.
22. Doraiswamy PM, Krishnan KR, Oxman T, Jenkyn LR, Coffey DJ, Burt T, Clary CM. Does antidepressant therapy improve cognition in elderly depressed patients?. J Gerontol A Biol Sci Med Sci 2003, 58:M1137-1144.
23. Narushima K, Chan KL, Kosier JT, Robinson RG. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression. Am J Psychiatry 2003, 160:1157-1162. 10.1176/appi.ajp.160.6.1157, 12777275.
24. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004, 127:212-219. 10.1093/brain/awh023, 14607791.
25. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007, 78:702-706. 10.1136/jnnp.2006.103549, 2117663, 17210627.
26. O'Brien JT, Firbank MJ, Krishnan MS, van Straaten EC, van der Flier WM, Petrovic K, Pantoni L, Simoni M, Erkinjuntti T, Wallin A, Wahlund LO, Inzitari D. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: The LADIS study. Am J Geriatr Psychiatry 2006, 14:834-841.
27. Poels MM, van Oijen M, Mattace-Raso FU, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. Arterial stiffness, cognitive decline, and risk of dementia: The Rotterdam study. Stroke 2007, 38:888-892. 10.1161/01.STR.0000257998.33768.87, 17272780.
28. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997, 54:915-922.
29. Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: A systematic review. J Neurol Neurosurg Psychiatry 2008, 79:619-624. 10.1136/jnnp.2007.124651, 17717021.
30. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346:476-483. 10.1056/NEJMoa011613, 11844848.
31. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003, 53:214-221. 10.1002/ana.10440, 12557288.
32. Taylor MJ, Carney S, Geddes J, Goodwin G. Folate for depressive disorders. Cochrane Database of Systematic Reviews: Reviews 2003, (2):CD003390. John Wiley & Sons, Ltd Chichester.
33. Rowan EN, Dickinson HO, Stephens S, Ballard C, Kalaria R, Kenny RA. Homocysteine and post-stroke cognitive decline. Age Ageing 2007, 36:339-343. 10.1093/ageing/afm006, 17363393.
34. Meiklejohn DJ, Vickers MA, Dijkhuisen R, Greaves M. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 2001, 32:57-62.
35. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 2004, 291:565-575. 10.1001/jama.291.5.565, 14762035.
36. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567-1577. 10.1056/NEJMoa060900, 16531613.
37. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578-1588. 10.1056/NEJMoa055227, 16531614.